InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-02 · accession 0001628280-24-052606 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2024-12-30 2024-12-02+ CPIX KAZIMI A J COB, CEO, Dir, 10% P - Purchase $1.71 +769 5.70M +0.0% +$1,318

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-04 P A 70 $1.22 5,701,737 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
2 Common Common Stock 2024-12-03 P A 70 $1.26 5,701,667 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
3 Common Common Stock 2024-12-02 P A 70 $1.33 5,701,597 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
4 Common Common Stock 2024-12-20 P A 39 $2.35 5,702,296 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
5 Common Common Stock 2024-12-19 P A 40 $2.33 5,702,257 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
6 Common Common Stock 2024-12-18 P A 49 $2.19 5,702,217 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
7 Common Common Stock 2024-12-17 P A 49 $2.12 5,702,168 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
8 Common Common Stock 2024-12-16 P A 49 $2.21 5,702,119 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
9 Common Common Stock 2024-12-13 P A 32 $2.33 5,702,070 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
10 Common Common Stock 2024-12-12 P A 32 $2.19 5,702,038 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
11 Common Common Stock 2024-12-11 P A 32 $2.29 5,702,006 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
12 Common Common Stock 2024-12-10 P A 32 $2.48 5,701,974 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
13 Common Common Stock 2024-12-05 P A 65 $1.20 5,701,802 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
14 Common Common Stock 2024-12-06 P A 70 $1.20 5,701,872 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.
15 Common Common Stock 2024-12-09 P A 70 $1.25 5,701,942 D — — (F1) The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.